Generate Biomedicines, Inc. (GENB) vs Palvella Therapeutics, Inc. (PVLA)
A side-by-side comparison of Generate Biomedicines, Inc. and Palvella Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GENB
Generate Biomedicines, Inc.
$13.80HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PVLA
Palvella Therapeutics, Inc.
$128.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — GENB vs PVLA
growth of $100 · dividends reinvested · last 1yGENB +10.0% (+10.0%/yr)PVLA -2.1% (-2.1%/yr)GENB compounded faster over this window
GENB PVLA
GENB vs PVLA: by the numbers
- •PVLA is the larger company ($1.84B vs $1.77B market cap).
- •Both run net losses; PVLA's is the smaller (0.00% vs -636.99% net margin).
Metrics side by side
Valuation
| Metric | GENB | PVLA |
|---|---|---|
| P/B ratio | 3.88 | 8.47 |
Profitability
| Metric | GENB | PVLA |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -737.04% | 0.00% |
| Net margin | -636.99% | 0.00% |
| ROE | N/A | -28.45% |
| ROIC | -94.79% | -23.90% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.